An experimental platform for laser-driven ion (sub-MeV) acceleration and potential applications was commissioned at the HiLASE laser facility. The auxiliary beam of the Bivoj laser system operating ...at a GW level peak power (~10 J in 5–10 ns) and 1–10 Hz repetition rate enabled a stable production of high-current ion beams of multiple species (Al, Ti, Fe, Si, Cu, and Sn). The produced laser–plasma ion sources were fully characterized against the laser intensity on the target (1013–1015 W/cm2) by varying the laser energy, focal spot size, and pulse duration. The versatility and tuneability of such high-repetition-rate laser–plasma ion sources are of potential interest for user applications. Such a statistically accurate study was facilitated by the large amount of data acquired at the high repetition rate (1–10 Hz) provided by the Bivoj laser system.
An experimental platform for laser-driven ion (sub-MeV) acceleration and potential applications was commissioned at the HiLASE laser facility. The auxiliary beam of the Bivoj laser system operating ...at a GW level peak power (~10 J in 5–10 ns) and 1–10 Hz repetition rate enabled a stable production of high-current ion beams of multiple species (Al, Ti, Fe, Si, Cu, and Sn). The produced laser–plasma ion sources were fully characterized against the laser intensity on the target (10sup.13–10sup.15 W/cmsup.2) by varying the laser energy, focal spot size, and pulse duration. The versatility and tuneability of such high-repetition-rate laser–plasma ion sources are of potential interest for user applications. Such a statistically accurate study was facilitated by the large amount of data acquired at the high repetition rate (1–10 Hz) provided by the Bivoj laser system.
The outcome of keratorefractive procedures such as PRK and LASIK is limited by the wound-healing process in the corneal stroma, which gives rise to complications such as haze formation and ...regression. The proliferation and matrix synthesis of corneal stromal fibroblasts is the central element of the wound-healing process. In order to develop new therapeutic strategies to reduce wound-healing intensity, we investigated the effect of heparin on the proliferation of cultured human corneal stromal fibroblasts (HCF) alone and in the presence of growth factors.
Primary cultures of HCF were established using epithelium and endothelium-free explants. Secondary cultures of HCF (first passage), cultured in WM/F12 supplemented with 10 microg/ml transferrin and 10 microg/ml thyroglobulin (LR-1 medium), 1% fetal calf serum (FCS) and 10% FCS were used to determine the effect of heparin on the proliferation of HCF in concentrations ranging from 12.5 microg/ml to 5000 microg/ml. Cell number was determined using the CASY 1 cell counter system. Modulation of HCF proliferation by heparin (50 microg/ml and 2000 microg/ml) was also investigated under serum-free conditions and in the presence of bFGF, EGF and PDGF-BB.
Addition of heparin led to a dose-dependent inhibition of proliferation after 6 days of incubation, which was statistically significant for 500-5000 microg heparin/ ml (FCS 1%) and for 200-5000 microg heparin/ml (FCS 10%). IC50 values for this effect were determined to be approximately 700 microg heparin/ml. When cultured under serum-free conditions (LR-1), a significant reduction of cell number was only observed with 5000 microg heparin/ml. There was no significant modulation of PDGF-BB-, bFGF-, or EGF-stimulated cell proliferation by heparin at concentrations of 50 microg/ml and 2000 microg/ml after 6 days of incubation.
Our observations indicate that heparin can inhibit proliferation of HCF effectively. The results of the present study could eventually pave the way to prevent anterior stromal haze formation and regression after keratorefractive surgery.
PDF
